Deniz Yuret is a Professor in the Department of Computer Engineering at Koç University , Istanbul, and the founding director of the KUIS AI Center . Previously, he spent 12 years at the MIT AI Lab and co-founded Inquira, Inc. His research focuses on Natural Language Processing and Machine Learning , with significant contributions in dependency parsing , language modeling , grounded language learning , and character-level NLP . He has pioneered frameworks like Knet , a deep learning library in Julia, and AutoGrad.jl for automatic differentiation. Deniz's academic work spans neural architectures for language-robot interaction, transfer learning in low-resource NMT, and context embeddings for grammatical category acquisition. His recent publications emphasize transformer models , multimodal systems , and efficient language modeling . He has supervised multiple graduate students, including Emre Can Açıkgöz (PhD, UIUC), Onur Kuru (M.S. 2016), Saman Zia (M.S. 2016), and Osman Baskaya (M.S. 2015). His projects include the TUBITAK 1001 (2016-2018) and ReGROUND (2015-2018) in collaboration with international institutions.
Hoda Eldardiry is an Associate Professor in the Department of Computer Science at Virginia Tech, where she directs the Machine Learning Laboratory. Her research focuses on artificial intelligence and machine learning, particularly in building human-machine collaborative AI systems that can learn context-aware and explainable models from multisource and interconnected data. Prior to joining Virginia Tech, she led research at Palo Alto Research Center (Xerox PARC) in the machine learning research group. Dr. Eldardiry received her educational qualifications from: BE in Computer and Systems Engineering from Alexandria University, Egypt MS and PhD in Computer Science from Purdue University Her research interests span multiple domains of AI and machine learning. She specializes in robust machine learning for information extraction, forecasting, and control. Her work integrates graph neural networks, time-series analysis, and relation extraction to develop explainable and context-aware AI systems. She also investigates the intersection of AI with ethics, policy, and governance, exploring how to build responsible AI systems that align with human values and societal needs. Dr. Eldardiry's recent publications demonstrate a strong focus on advancing graph-based time-series modeling, zero-shot learning techniques, and optimal control systems. Her work bridges theoretical advancements with practical applications in healthcare, transportation, and e-commerce. She has made significant contributions to knowledge graph construction, explainable AI, and federated learning frameworks that operate efficiently in resource-constrained environments. Her scientific achievements have been recognized with several prestigious awards: Purdue University College of Science Early Career Scientist Award for the Department of Computer Science (2021) Honorable Mention Best Paper Award for Exploring Approaches to Artificial Intelligence Governance: From Ethics to Policy (IEEE Ethics 2023) Most Cited Paper Award for COVID-19 Pandemic Impacts on Traffic System Delay, Fuel Consumption and Emissions (2023) Purdue CS Women's History Month Celebration Recognition (2022) VT CS Women's History Month Celebration Recognition (2023) Early Career Distinguished Scientist Award from Purdue University College of Science (2021) Purdue University College of Science Distinguished Alumni (2021) Dr. Eldardiry has successfully secured substantial research funding, with total grant funding of $27,424,460 ($13,808,328 share) from diverse sources including VT, IARPA, DOE, NSF, DARPA, NIH-iTHRIV, CCI, EBAY, SIEMENS, ADOBE, P&G and XEROX. Her current projects include NSF-funded research on Advancing Health Equity using Interactive Condition Assessment and Monitoring and Exploring How AI Engineers Perceive and Develop Translational Ethical Competency, as well as industry collaborations with EBAY on Heterogeneous Hypergraph Modeling for Zero-Shot Product Aspect Identification. As director of the Machine Learning Laboratory at Virginia Tech, Dr. Eldardiry leads a research team that bridges theoretical AI advancements with real-world applications. Her lab collaborates extensively with industry partners and government agencies to develop practical AI solutions while maintaining a strong commitment to ethical considerations and societal impact.
Joan Lluís Pijoan Vidal is a Professor at the Department of Engineering, La Salle Campus Barcelona, Ramon Llull University, currently serving as Director of the Telecommunication Systems Engineering degree and leading the Research Group on Internet Technologies & Storage (GRITS). His academic credentials include: MsC in Telecommunications from Polytechnical University of Catalonia (UPC) in 1994 PhD from Ramon Llull University (URL) in 2000 Professor Pijoan's research focuses on adaptive multicarrier modulations for HF communications , NVIS (Near Vertical Incidence Skywave) , and Power Line Communications , with significant applications in Antarctic sensor networks and Internet of Things infrastructure. His work bridges theoretical signal processing with practical field implementations in extreme environments. His publication portfolio (30 journal articles, 70+ conference papers) reveals consistent expertise in wireless channel modeling, resource allocation for OFDMA systems, and power line communication technologies, often validated through Antarctic field tests. Recent work emphasizes IoT integration in harsh environments like the SHETLAND-NET and XIoT projects. He has supervised over 190 master's/bachelor's theses and 8 PhD dissertations while directing 19 research projects, including Antarctic sensor communications under ENVISERA. His leadership extends to European COST Actions and industry technology transfer initiatives with IT companies. Currently heading GRITS, he previously directed the Catalan Government-awarded GRECO research group (2001-2014) and served as Department Head of Communications and Signal Theory for a decade.
Stirling Churchman, Ph.D., is Professor of Genetics at Harvard Medical School and leads the Churchman Lab within the Blavatnik Institute. Her work integrates experimental and computational approaches to dissect the multiple layers of gene regulation, spanning transcription, RNA processing, and translation in both nuclear and mitochondrial systems. Education: While specific degrees are not detailed in the provided text, Dr. Churchman’s extensive publication record and faculty position at Harvard Medical School indicate advanced graduate and postdoctoral training in molecular biology and genomics. Research Interests: Nascent RNA dynamics: Using NET-seq and nanopore direct RNA sequencing to capture transcription and co-transcriptional processing at single-nucleotide resolution. Mitochondrial gene expression: Investigating how mitochondrial transcription and translation are synchronized with nuclear programs to maintain respiratory chain homeostasis. Chromatin architecture & single-molecule genomics: Employing Fiber-seq to visualize RNA polymerases and chromatin structure along native DNA fibers up to 30 kb in length. Post-transcriptional splicing kinetics: Quantifying intron removal dynamics in living cells to understand fidelity and timing of mRNA maturation. Across more than 60 publications (2011-2025), a clear trend emerges: Dr. Churchman develops cutting-edge sequencing technologies and applies them to fundamental questions in gene expression. Recent work (2024-2025) highlights a shift toward mitochondrial biology, antibiotic action on mitoribosomes, and the global quantification of RNA flow across cellular compartments. Scientific Awards & Honors: Specific named awards are not listed in the provided text; however, her continuous funding, high-impact publications, and professorial appointment at Harvard Medical School reflect significant peer recognition. Laboratory & Team: The Churchman Lab is located in the New Research Building at Harvard Medical School (Blavatnik Institute, Room 356). The team is interdisciplinary, combining expertise in biology, physics, chemistry, and computation to pursue integrative studies of gene regulation. Funding & Grants: While explicit grant numbers are not provided, the sustained productivity, large team, and resource-intensive technologies (e.g., nanopore sequencing, cryo-EM collaborations) indicate substantial and ongoing extramural funding from NIH and other agencies.
Prof. Dr.-Ing. Sebastian Esser serves as Group Lead for Information Management at the Chair of Computing in Civil and Building Engineering at Technical University of Munich. His research focuses on advancing Building Information Modeling (BIM) methodologies, particularly in infrastructure and railway applications. He contributes significantly to international standardization efforts including IFC-Road and IFC-Rail projects, and leads research initiatives such as RIMcomb and BauPuls360. Dr. Esser's research spans several critical areas in digital construction: Graph-based version control systems for BIM collaboration Digital twin development for infrastructure management Semantic modeling of built environments BIM-based regulation checking for railway infrastructure Interdisciplinary model coordination techniques Knowledge representation in civil engineering His work bridges theoretical computer science with practical civil engineering applications, focusing on improving data interoperability and workflow efficiency in construction projects. Analysis of his recent publications reveals a strong emphasis on graph-based approaches to BIM challenges. His research has evolved from foundational work on BIM programming interfaces to sophisticated implementations involving knowledge graphs, semantic reasoning, and digital twin architectures. Key trends include increasing integration of semantic web technologies with BIM standards, development of specialized query interfaces like GraphQL for construction data, and application of formal methods to infrastructure modeling problems. Dr. Esser actively supervises numerous bachelor's and master's theses annually, with recent topics covering graph-based entity alignment, BIM-GIS integration for flood assessment, incremental model updates, and digital twin implementations. His teaching portfolio includes courses such as Bau- und Umweltinformatik, BIM.fundamentals, BIM.infra, and Semantic Modeling of the Built World, demonstrating his commitment to educating the next generation of digital construction professionals. He is involved in multiple research initiatives including DFG FOR 5672 (The information backbone of robotized construction), SPP 2187 (Adaptive modularized constructions), and AM2PM (Additive to Predictive Manufacturing). His laboratory work spans the BIM-Lab and related computational infrastructure supporting his research in digital construction technologies.
Professor Ute Schmid is a Full Professor of Cognitive Systems at the University of Bamberg, where she has been a faculty member since September 2004. She leads the Cognitive Systems Group within the Bamberg Center of AI (BaCAI), focusing on creating AI systems that generate human-like explanations and reasoning processes. Her research bridges cognitive science and artificial intelligence to develop methods for explanation generation, inductive programming, and interactive machine learning. Professor Schmid's work emphasizes practical applications of explainable AI across diverse domains including image classification, medical diagnosis, and educational technologies. Her research on contrastive explanations, near misses, and human-AI alignment has significantly advanced the field of XAI. She has also pioneered research on AI literacy, recognizing the growing importance of basic AI understanding for responsible tool usage by non-experts. Her publication record demonstrates exceptional productivity and impact, with numerous articles in top-tier venues including Nature Machine Intelligence, IEEE Transactions on Visualization and Computer Graphics, and the Journal of Web Semantics. Her 2025 paper 'Aligning generalization between humans and machines' represents a significant theoretical contribution to understanding human-machine cognitive alignment. Professor Schmid actively contributes to gender diversity research in computer science through studies examining why women pursue PhDs in the field. She has also made important contributions to computing education, investigating how students acquire programming skills and how AI tools like code generators are integrated into learning processes. As an educator and researcher, Professor Schmid maintains strong international collaborations, with co-authors spanning multiple countries and institutions. Her interdisciplinary approach is evident in her diverse publication venues and collaborative work that bridges computer science, cognitive science, education, and application domains.
Altti Ilari Maarala is a Researcher specializing in computational genomics and bioinformatics, with active participation in multiple Academy of Finland-funded cancer research initiatives. His work bridges computer science and genomics through scalable computational methods. Research Focus Altti develops distributed computing solutions for genomic data challenges, including: Pan-genome indexing and compressed data structures for sequence alignment Spark-based frameworks for genome assembly and genotype imputation High-throughput sequencing analytics in population genomics Visualization tools for tumor evolution dynamics Active Projects Key collaborative efforts: DYNAMITE (2025-2028): Targeting transcription factor dynamics in ovarian cancer therapy MULTISTANC (2025-2027): Multi-modal data integration to overcome chemotherapy resistance iCAN Digital Precision Cancer Medicine (2022-2026): Flagship program for data-driven oncology Publication Trends Altti's recent work emphasizes scalable cloud-based genomics, with publications focusing on distributed algorithms for genome assembly (Spark), compressed pan-genome indexing, population-scale data analytics, and cancer evolution visualization. His research consistently integrates high-performance computing with biological data challenges.
Jaan-Olle Andressoo is a Professor at the Department of Pharmacology, University of Helsinki, affiliated with the Faculty of Biology and Environmental Sciences. He serves as supervisor for multiple doctoral programs including Brain & Mind, Drug Research, and Integrative Life Science. His research focuses on biomedicine, neuroscience, and pharmacology, particularly investigating the role of GDNF (Glial Cell Line-Derived Neurotrophic Factor) in neurodevelopment and neurodegenerative diseases. Current projects examine motor learning mechanisms in Purkinje cells, intestinal neurobiology, and Parkinson's disease models. Pioneer Innovator Grant (Novo Nordisk Fonden, 2025-2026) Juselius Foundation Grant (2025-2026) EU Horizon Research Action (2025-2028) Recent publications highlight his work on protein evolutionary analysis, GDNF regulation of neuronal development, and metabolic interventions in Parkinson's disease models. His research integrates developmental genetics with translational medicine.
Allen Holder is a Professor of Mathematics at Rose-Hulman Institute of Technology with research affiliations at Indiana University School of Medicine, Cancer Therapy Research Center (San Antonio), and Huntsman Cancer Center (Salt Lake City). His work bridges optimization theory with real-world applications in medicine, biology, and industrial systems. Education PhD, University of Colorado-Denver, 1998 MS, University of Southern Mississippi, 1993 BS, University of Southern Mississippi, 1990 Dr. Holder specializes in mathematical programming applied to computational biology (protein structure alignment, metabolic networks), medical physics (radiotherapy optimization), and industrial engineering (foundry scheduling). His cross-disciplinary approach has driven the establishment of Rose-Hulman's biomathematics major and enabled breakthroughs like a 1000x faster protein analysis algorithm developed with Dr. Yosi Shibberu. His 2011-2015 publications reveal a consistent pattern of applying operations research to high-impact biological and medical challenges, particularly in genome-scale modeling and radiation oncology optimization, while maintaining industrial applications in scheduling. Scientific Recognition Board of Trustees Outstanding Scholar (2015) 4-time Blue Key Favorite Professor (2001,2003,2005,2006) INFORMS Moving Spirit Award (2003) 2-time Alpha Lambda Delta Professor of the Month (2000,2003) Dr. Holder has mentored nearly 50 undergraduate researchers and serves as editor for multiple publications. His collaborative grants span medical centers and industrial partners, focusing on translating optimization theory into clinical and manufacturing solutions. He leads cross-institutional teams including Rose-Hulman biology/chemistry faculty, Indiana University medical researchers, and cancer center specialists, driving translational projects from algorithm development to clinical implementation.
Feng Cui is an Associate Professor in the Thomas H. Gosnell School of Life Sciences at Rochester Institute of Technology (RIT), where he serves as Graduate Director of the Bioinformatics MS Program and is an affiliated faculty member of the Golisano College for Computing and Information Sciences. He holds the position of Faculty Senator (Alternate) and maintains an active research laboratory focused on computational biology and bioinformatics. His educational background includes an MS from Truman State University, a Ph.D. in Bioinformatics and Computational Biology from Iowa State University, and an MD from Hunan Medical University in China. Following his doctoral studies, he completed postdoctoral training at the National Cancer Institute (NCI). Dr. Cui's research spans three primary areas: exploring nucleosomal DNA diversity, developing machine learning approaches to predict nucleosome-binding proteins, and applying artificial intelligence to medical and systems biology challenges. His work combines computational approaches with biological insights to address fundamental questions in chromatin structure and develop practical applications for disease diagnosis and treatment. His publication record from 2012-2023 demonstrates consistent output in high-impact journals including Nucleic Acids Research, BMC Bioinformatics, and Frontiers in Bioinformatics. His recent work shows a clear progression toward increasingly sophisticated AI applications in biology, with a growing emphasis on deep learning techniques for medical applications, particularly in cancer research and virology. Dr. Cui actively mentors students at multiple levels, with numerous undergraduate and graduate researchers contributing to his projects. His laboratory has been supported by funding from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under award number R15GM149587. The Cui Research Group maintains a strong focus on the interface between computer science and biology, with current projects investigating nucleosomal DNA patterns, machine learning prediction of protein-DNA interactions, and AI applications for medical diagnostics. The lab has developed several computational tools including nuMap for nucleosome positioning prediction and ProtGauss for predicting nucleosome binding modes.
Kiril Kirilov serves as an Assistant Professor in the Department of Biological Sciences at New Bulgarian University (NBU) since 2022, following 15 years of research at the Institute of Molecular Biology, Bulgarian Academy of Sciences (IMB-BAS) where he completed his PhD dissertation on bacterial and mitochondrial codon usage. His academic foundation includes specialized bioinformatics training at Italy's International Centre for Genetic Engineering and Biotechnology (2003) and Canada's Carleton University (2013). His educational milestones feature: Master's degree in Engineer Biotechnologist from the University of Chemical Technology and Metallurgy, Sofia (2001) PhD in Molecular Biology from the Institute of Molecular Biology, Bulgarian Academy of Sciences (2014) Kirilov's research operates at the intersection of computational and experimental biology, with three dominant thematic clusters emerging from his publication record. His foundational work in bioinformatics focuses on codon usage patterns across bacterial and mitochondrial genomes, developing specialized algorithms for genomic analysis. A significant experimental stream investigates glycation processes in aging and disease, examining molecular interactions between compounds like L-lysine and proteins such as histone H1. Most recently, his work has expanded into neurodegenerative disease mechanisms , exploring neurotensin analogs for Parkinson's disease and novel galantamine derivatives for Alzheimer's treatment, often incorporating nutraceutical approaches like lycopene analysis. His publication trajectory reveals a strategic evolution from pure molecular genetics toward translational biomedical applications, consistently applying computational rigor across diverse biological systems. The 2023 Parkinson's disease study exemplifies this integration, combining receptor pharmacology with animal model validation. Patent development for chemistry education tools further demonstrates his commitment to knowledge transfer beyond traditional academic boundaries. At NBU, Kirilov teaches GENB093 History of Science while maintaining active research collaborations across Bulgarian academic institutions, with email correspondence facilitated through kkirilov@nbu.bg.
Michelle Scott is a Full Professor in the Department of Biochemistry and Functional Genomics at the University of Sherbrooke's Faculty of Medicine and Health Sciences, with a concurrent appointment in the Computer Science Department. Her academic trajectory shows progressive advancement from Assistant Professor (2011) to Associate Professor (2016), culminating in her current Professorship (2021). She directs an active research program focused on non-coding RNA biology, particularly small nucleolar RNAs (snoRNAs), with emphasis on their roles in ovarian cancer and transcriptomic regulation. Her research interests center on bioinformatic characterization of RNA networks , development of computational tools for RNA-seq analysis (including CoCo and snoDB), and molecular mechanisms of snoRNAs in cancer . Recent work employs low-structure-bias sequencing (TGIRT-seq) to overcome technical limitations in transcriptome analysis, revealing previously undetected non-coding RNAs and non-canonical snoRNA functions. Her group investigates snoRNA roles in alternative splicing regulation, cancer progression (particularly high-grade serous ovarian carcinoma), and nucleolar biology. The 15 most recent publications demonstrate strong focus on methodological innovation in transcriptomics (6 articles), snoRNA functional characterization (5 articles), and cancer genomics applications (4 articles). Key trends include addressing RNA-seq reproducibility issues, developing computational frameworks for multi-mapped read resolution, and expanding the functional landscape of snoRNAs beyond canonical roles. FRQS Senior Researcher Fellowship (2025) RECMUS Award for Supervision Excellence (2021) Tremplin Award for Early-Career Research (2021) Multiple FRQS Junior Fellowships (2017, 2021) Dean's List for Exceptional Performance (2015-2021) Scott has successfully mentored numerous graduate students (including 15 first-author publications by trainees) and secured substantial competitive funding, including a $$1\text{,}525\text{,}000$$ CIHR Project Grant (2021-2026) on proteogenomics approaches to define the human proteome. Her laboratory maintains strong affiliations with the CHUS Research Center and actively participates in the RiboClub network, which she has organized since 2014. Current work focuses on characterizing nucleolar snoRNAs in ovarian cancer and improving transcriptomic annotation frameworks.
Weigang Qiu is a Professor in the Department of Biological Sciences at Hunter College, part of the City University of New York (CUNY). His research focuses on the population genomics of microbial pathogens, particularly the Lyme disease bacterium Borrelia burgdorferi . Dr. Qiu received his educational training from: BS in Biochemistry from Fudan University, China (1986) PhD in Ecology and Evolution from State University of New York at Stony Brook (1999) Postdoctoral training in Bioinformatics at University of Maryland Biotechnology Institute (2002) Dr. Qiu's research interests center on evolutionary bioinformatics and pathogen variability. His lab specializes in comparative analysis of multiple genomes of the Lyme disease pathogen, reconstructing the history of worldwide diversification of Lyme disease bacteria, understanding mechanisms of genome evolution (particularly roles of recombination and natural selection), and inference of gene and genome functions. His approach is primarily bioinformatics-based, focusing on computational and statistical testing of evolutionary hypotheses. Students in his lab learn modern computational tools including relational databases/SQL, Perl/BioPerl, and statistical computing with R. Analysis of Dr. Qiu's publication record shows a consistent focus on Lyme disease pathogens and bacterial evolution, with recent work expanding into cancer biology and thyroid cancer research. His research demonstrates interdisciplinary connections between evolutionary biology, microbiology, and medical applications, highlighting how evolutionary principles can inform our understanding of disease mechanisms. Dr. Qiu teaches several courses including Molecular Evolution (BIOL 375), Computational Molecular Biology (BIOL 425), Bioinformatics Summer Workshop (BIOL 470), and Microbiology (BIOL 230). He is also involved in the QuBi Project for curricular improvement in quantitative biology. Dr. Qiu leads the Qiu Lab, which focuses on bioinformatics tools development for bacterial genomics research. The lab has developed several specialized tools including: Borrelia Ortholog Retriever: For obtaining ortholog alignments from 23 Borrelia spp genomes SimBac: A package for simulating bacterial genome evolution DNATweezer: A Perl wrapper of BioPerl modules The Bio::Align::Graphics module
Sarah Rennie serves as Assistant Professor in the Department of Biology within the Faculty of Science at the University of Copenhagen, specializing in Computational and RNA Biology. Her research focuses on RNA modifications and their implications in cancer biology, particularly gastrointestinal and pancreatic cancers. Her primary research interests span RNA modifications, noncoding RNA biology, cancer epigenetics, and bioinformatics. Current work investigates N6-methyladenosine (m6A) modifications in pancreatic cancer progression, tumor microenvironment adaptations, and computational approaches for RNA analysis. Her lab develops and benchmarks bioinformatic tools for lncRNA research and RNA editing detection, bridging wet-lab experiments with computational modeling. Recent publications demonstrate significant contributions to understanding RNA modification roles in cancer, with 2024-2025 work appearing in high-impact journals including Cancer Science , Cell Reports , and EMBO Journal . Her research shows strong emphasis on translational applications, particularly in developing RNA-based cancer biomarkers and therapeutic targets. Rennie serves as Editor for the journal Non-coding RNA (2023), demonstrating leadership in the field. Her work receives consistent attention across academic platforms with multiple mentions on X (formerly Twitter), Reddit, Bluesky, and Mendeley. Her laboratory operates within the Computational and RNA Biology section at Ole Maaløes Vej 5 in Copenhagen, utilizing both experimental and computational approaches to study RNA modifications in disease contexts. Current projects focus on acid microenvironment adaptations in pancreatic cancer and deep learning applications for RNA modification analysis.
Laura Elo serves as Professor at the University of Turku and holds dual leadership roles as Research Director of Turku Bioscience Centre and Vice Director of Turku Life Science Center. She is a key figure in the InFLAMES Flagship research program focused on inflammation mechanisms. Her primary affiliation is with the Computational Biomedicine department where she leads the Elo Lab. Her research spans computational biomedicine with emphasis on proteomics, metabolomics, and machine learning applications in disease modeling. Key focus areas include longitudinal analysis of type 1 diabetes, obesity-related metabolic pathways, malaria resistance mechanisms, and single-cell immunology. She develops computational methods for cell migration analysis (CellRomeR package) and metagenomic data processing. Recent publications demonstrate strong interdisciplinary collaboration across bioinformatics, clinical medicine, and systems biology. Her work frequently appears in high-impact journals including Science , Scientific Reports , and American Journal of Physiology , with multiple 2025 publications highlighting cutting-edge computational approaches to complex diseases. Laura Elo actively disseminates research through platforms like Tekniikan Maailma (The World of Technology), making computational medicine accessible to broader audiences. Her leadership extends to organizing major events like the European Conference on Computational Biology (ECCB2024). The Elo Lab maintains strong industry and clinical partnerships, evidenced by large-scale studies using Nordic Arthroplasty Register data and collaborations with Turku Metabolomics Core. Current projects integrate multi-omics data with clinical outcomes to improve disease diagnosis and treatment prediction.
